CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785

Negative
AI Analysis

Summary

Cantor Fitzgerald reduced its price target on Regeneron Pharmaceuticals from $785 to $750 per share, indicating a more cautious outlook on the company's near-term prospects.

Importance:2/10
Sentiment:
-0.30
price target reductionanalyst noteequity research
Related Companies

Read the original article

Published by yahoo_finance on July 21, 2026 4:22 PM

Read Original